Skip to Main Content

Top of the morning, and what a cold one it is. A bit of an arctic freeze has descended upon many of us on this side of the pond, but we are keeping warm thanks to — you guessed it — multiple cups of stimulation. This is why coffee kettles were invented, after all. So fire it up, pour a hot one, and please enjoy the tidbits below. Hope your day goes well and you remain toasty …

When two generic drug makers scrambled last July to recall hundreds of lots of the valsartan blood pressure drug, a third company unaffected by the recall saw a “one-off opportunity” to significantly increase prices, USA Today writes. Teva Pharmaceutical (TEVA) and Prinston Pharmaceutical recalled the meds after testing revealed small amounts of a probable carcinogen, but the same drugs produced by Alembic Pharmaceuticals did not show contamination. And Alembic more than tripled the price of 17 of its own formulations of valsartan, from 329 percent to 469 percent.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Comments are closed.